SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-024914
Filing Date
2022-06-30
Accepted
2022-06-30 13:28:17
Documents
14
Period of Report
2022-06-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abcl-8k_20220629.htm   iXBRL 8-K 45514
2 EX-99.1 abcl-ex991_6.htm EX-99.1 11815
3 GRAPHIC gsdpesv111xg000001.jpg GRAPHIC 9155
  Complete submission text file 0001564590-22-024914.txt   199139

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA abcl-20220629.xsd EX-101.SCH 5593
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20220629_lab.xml EX-101.LAB 18576
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20220629_pre.xml EX-101.PRE 11040
8 EXTRACTED XBRL INSTANCE DOCUMENT abcl-8k_20220629_htm.xml XML 3390
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 221057345
SIC: 2834 Pharmaceutical Preparations